
Duluth News Tribune (12.28.02) - Tuesday, December 31, 2002
Melanie Evans
Patients hospitalized at two hospitals in Duluth, Minn. - St. Mary's and Miller-Dwan - between Nov. 1 and Dec. 3 may have had contact with the ill doctor, said Beth Johnson, an SMDC spokesperson. On Dec. 4, the hospital notified Minnesota's Health Department of the contagious patient. He had not returned to practice by Friday, Johnson said.
As many as 90 patients came into contact with the TB- infected doctor shortly before or after the physician's symptoms, which included a phlegmy cough, emerged in early November. However, only 20 patients - those with the frequent, close and lengthy contact needed to spread the bacteria - will be asked to be tested for recent infection, said St. Louis County epidemiologist Larry Sundberg. It is not yet certain how many SMDC employees had close enough contact to be considered at risk for an infection, Johnson said. If tests turn up positive, doctors may prescribe a nine-month course of antibiotics to kill the bacteria.
Meanwhile, the doctor's illness prompted the health system to move a yearly TB screening from March to February. An estimated 2,500 SMDC employees who work in downtown Duluth undergo the skin test each year, Johnson said, and perhaps two or three test positive for a new infection.
This is the second case of active TB in St. Louis County for 2002. In 2001, there were four contagious infections, with Minnesota reporting 239 cases.
021231
AD022521
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.